Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF)
| Autor: | Camila M. Malnarcic, Beverley C Millar, J. McCaughan, John E. Moore |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Cystic Fibrosis business.industry Pseudomonas aeruginosa Levofloxacin Microbial Sensitivity Tests Awareness medicine.disease_cause medicine.disease Cystic fibrosis Anti-Bacterial Agents Ciprofloxacin Health Occupations Internal medicine medicine Immunology and Allergy Humans Pseudomonas Infections business Genetics (clinical) medicine.drug |
| Zdroj: | The clinical respiratory journal. 14(1) |
| ISSN: | 1752-699X |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|